文献速递乳腺乳腺X线MRUS

乳腺导管原位癌的影像学:关于浸润性癌进展与主动监测的新进展

Radiology for Ductal Carcinoma In Situ of the Breast: Updates on Invasive Cancer Progression and Active Monitoring.
PubMed 文献 · Korean J Radiol · 2024-07-04

导管原位癌约占新发乳腺癌诊断的30%,其进展为浸润性癌的机制在组织病理学、遗传学和影像学上结论常相互矛盾。主动监测作为非手术管理策略,以密切影像随访替代手术,但面临识别隐匿性浸润癌和进展风险患者的挑战,目前有四项前瞻性主动监测试验正在进行。

要点

  • 导管原位癌约占新发乳腺癌诊断的30%,影像学在判断主动监测资格和随访监测疾病进展中起主要作用。
  • 主动监测的两大挑战是识别隐匿性浸润癌和判断有浸润癌进展风险的患者。
  • 四项前瞻性主动监测试验正在进行,以确定可行性并完善患者入选标准和随访间隔。

核心结论

  • 放射科医生在确定主动监测资格和审查监测影像以判断疾病进展方面发挥主要作用,未来几年公布的试验结果将支持多学科导管原位癌诊疗的新时代。

研究设计与样本

  • 综述性文章,总结了导管原位癌在组织病理学、遗传学和影像学上疾病进展机制的现有认识,并概述了正在进行的四项前瞻性主动监测试验。

临床应用与阅片要点

  • 放射科医生在确定患者是否符合主动监测资格以及审查监测影像以判断疾病进展方面发挥主要作用。

局限性

  • 原文指出,关于疾病进展机制在组织病理学、遗传学和影像学方面的结论常常相互矛盾。
  • 主动监测面临的两大挑战是识别隐匿性浸润癌和判断有浸润癌进展风险的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ductal carcinoma in situ (DCIS) accounts for approximately 30% of new breast cancer diagnoses. However, our understanding of how normal breast tissue evolves into DCIS and invasive cancers remains insufficient. Further, conclusions regarding the mechanisms of disease progression in terms of histopathology, genetics, and radiology are often conflicting and have implications for treatment planning. Moreover, the increase in DCIS diagnoses since the adoption of organized breast cancer screening programs has raised concerns about overdiagnosis and subsequent overtreatment. Active monitoring, a nonsurgical management strategy for DCIS, avoids surgery in favor of close imaging follow-up to de-escalate therapy and provides more treatment options. However, the two major challenges in active monitoring are identifying occult invasive cancer and patients at risk of invasive cancer progression. Subsequently, four prospective active monitoring trials are ongoing to determine the feasibility of active monitoring and refine the patient eligibility criteria and follow-up intervals. Radiologists play a major role in determining eligibility for active monitoring and reviewing surveillance images for disease progression. Trial results published over the next few years would support a new era of multidisciplinary DCIS care.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Grimm LJ. Radiology for Ductal Carcinoma In Situ of the Breast: Updates on Invasive Cancer Progression and Active Monitoring. Korean J Radiol. 2024. PMID: 39028009. doi:10.3348/kjr.2024.0117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。